This study is a systematic literature review and meta-analysis concerning the use of a testosterone synthetic analog, oxandrolone, and its use in severe adult burns.
Introduction
Burn injuries and their sequelae have been present for centuries as major importance world problems. It is referred that over 1.2 million individuals will sustain a burn injury every year in the USA, being that the majority of these lesions are small burns, treated in the ambulatory. However, approximately 60,000 cases are moderate or severe and require hospitalization for their treatment. Furthermore, it is estimated that 5,000 deaths occur every year in the USA due to Burns or their complications 1 .
Corroborating to ratify the importance of the burn patient, and the need for improvements in their care, Bull and Fisher, in 1949 , reported a 50% mortality rate for children (0-14) with 49%
TBSA, for young adults (15-44) with 46% TBSA, for individuals between 45 and 64 with a 27% TBSA and for those older than 65, 10% TBSA 2 . These statistics have improved considerably with the advances in critical patients care, with current data showing a 50% mortality rate in children up to 14 with 98% TBSA and in young adults with over 75%TBSA 3, 4 .
Data available through the Brazilian Burn Society indicate that, in Brazil, there are one million burn cases each year;
200 thousand are seen in emergency services and 40 thousand will need hospital admission. Burns area amongst the main external death causes in Brazil, second only to other violent causes, such as traffic accidents and manslaughter 5 . A study on a hospital in Brasilia demonstrated a 6.2% death rate in burn patients admitted to an emergency hospital 6 .
As shown, it is noted the importance of the optimization of burn patient care in its acute phase, in intensive care, as well as in the recovering and rehabilitation phases, not forgetting that prevention is the best treatment.
Severe Burns will cause a great increment in catabolic rates, leading to lean mass consumption and decrease in protein reserve. Decreasing the lean mass will lead to a deficiency in wound healing and in muscle-skeletal function [7] [8] [9] [10] [11] [12] [13] . Testosterone analogs have been reported in the literature as substances which will decrease protein loss and stimulate anabolism [14] [15] [16] [17] [18] .
Oxandrolone is a synthetic analog, 17 alpha-methyl, derived from testosterone with frequent use in a large number of critical patients, such as advanced hepatopathies, HIV, cardiac cachexia, major Burns and other hyper catabolic patients, showing restoration in lean mass together with improved nutrition [17] [18] [19] [20] .
However, few studies permeate oxandrolone anticatabolic action on major burn patients [21] [22] [23] . This action consists in diminishing protein and lean mass loss, shortening wound healing time and donor area reepithelisation, as well as possible hospital stay decrease 16, 17 .
Based on the knowledge related to this subject, the objective of this systematic review study is to list the effects of oxandrolone in major adult burn patients, since there are few studies related to this theme on the literature, what rectifies the lack of protocol and systematization for its use in major burns units. As such, this review intends to serve as evidence for the secure and systematic use of Oxandrolone in the acute treatment as well as in the rehabilitation of adult patients with severe burns.
Objectives
The objective of this study is to respond the question about the use of oxandrolone in adult patients with severe burns, in relation to the time of wound healing of donor site, the nitrogen loss and the body mass loss.
Methods
To attain this objective, a selection of studies was performed within the main databases and its results were analyzed through a meta-analysis, according to the protocols of COCHRANE
25
.
Selection Criteria
For selection criteria, the search was performed within the main health databases: MEDLINE, COCHRANE, EMBASE e LILACS, the period of February 2014, using the key words:
severe burn and oxandrolone. As filters, language was restricted to Portuguese, English and Spanish.
The first selection was done through reading the titles, excluding all articles which had children in the study. Later, other factor was the study design, being that clinical, randomized and prospective studies were selected.
As results,
-MEDLINE: the search produced 24 articles. Nine were excluded due to the title not being related to this search and seven were excluded because they included studies in children. Of the eight residual studies, two were literature reviews which were also excluded since they did not obey the inclusion criteria and six clinical trials, one was excluded for being retrospective and observational and other was selected to the systematic review. Of these five articles, four were included in the systematic review and one excluded after reading the abstract because it was not about the subject of this review.
-COCHRANE: 12 articles were presented: two systematic reviews were excluded for not being related to the search criteria of this research and ten controlled studies, of which five were exclude for being related to children or not corresponding to the theme. Four presented correspondence with those of MEDLINE -The other bases surveyed did not return any results.
Study Type
The four selected studies according to the search criteria were:
• Demling R. or Oxandrolone, The patients with major burns whom did not fit the inclusion criteria for either group were the control group.
The groups were characterized as such:
1. Deep burns, 2nd or 3rd degree over 50% TBSA, with at least half of the area needing skin grafting.
2. Deep burns, 2nd and 3rd degree over 25% TBSA, with comorbidities, such as: older than 60, malnutrition and adults with diabetes.
• Demling R, Orgill PD. Control Group (n=24) without the use of anabolic agents;
HGH Group (n=20), with patients using HGH at 0.1 mg/ kg, intramuscularly, starting 7 to 10 days post-burn;
and Oxandrolone Group (n=16) using Oxandrolone at 20mg/day orally, starting 7 to 10 days post burn. All patients received optimized nutrition primarily based on the basal metabolic rate, according to the method of Wilmore et al. 24 . After the first week, required calories were adjusted according to indirect calorimetric and respiratory coefficient. Follow up was up to the transfer to a rehabilitation center, with resolution of the metabolic response to trauma, with clean wounds in less than 15% of burn surface area.
• Demling R, Orgill PD. 
Data Acquisition and Analysis
Data analysis was performed through meta-analysis using as comparison factors averages, standard deviations and number of individuals in each group of the selected studies.
For data processing, an electronic tool known as "Comprehensive Meta Analysis" 26 was used. It is virtually available for tests, correlation coefficient, odds ratio and Fisher Z relation calculations. All data were displayed in tables and graphs ("florets plot") for a better results visualization.
Results

Outcomes submitted to Meta-analysis
The analysis of the outcomes in this study, aiming at analyzing the effects of Oxandrolone use in major burn patients, identified the following aspects:
• Donor area healing time 
Meta-analysis results
Data analysis presented in When metabolic rate and length of hospital stay are analyzed, there is no statistical difference. Metabolic rate is a normal response to burn injury and there was no difference on its increase between the two groups. Length of stay comparison was hindered because of the small number of patients and the lack of homogeneity amongst the groups. As gathered from the literature, it becomes clear that as the percentage of body mass loss increases, so do the complications.
A 10% body mass loss will lead to immune dysfunction; 20% to impaired wound healing; 30%, severe infections and 40%, death 27 .
As the catabolism increases, it will also lead to a proportional increase in nitrogen loss.
It is well accepted that a shorter donor area healing time is imperative, since there are few donor areas in major burn patients. Obviously, the faster healing occurs, the faster skin can be re-harvested, and consequently more wounded areas covered.
Major burns will lead to an increase in catabolic rates, leading to lean mass use and decreased protein storage. Lean mass loss will lead to healing and muscle-skeletal impairment [7] [8] [9] [10] [11] [12] [13] .
Testosterone analogs have been reported as substances which will lead to a lesser protein loss and to anabolism [14] [15] [16] [17] [18] .
Results in this study show that the use of Oxandrolone when compared to control (placebo or not) will lead to significant benefits, such as lesser body mass loss, lesser nitrogen loss and lesser donor area healing time.
The question mote for this meta-analysis has been answered in relation to the effects of Oxandrolone on the recovering of major burn patients. The benefits shown in each study and their results meta-analysis may serve as evidence for the introduction of this treatment in more burn centers which currently are not using it, possibly considering risks, which are not present in this study, in relation to this anabolic agent use.
Conclusion
Clinical Practice Implications
As this study has shown a lesser body mass loss, lesser nitrogen loss and lesser donor area healing time with this anabolic agent, we can suggest the adoption of Oxandrolone use for patients whom present with body mass loss, increase in nitrogen loss or hindered donor area or superficial burn wound healing.
Oxandrolone use in burn centers should be more frequent, in an attempt to create a better critically ill patient management protocol. This could lead to a shorter recovering and rehabilitation time, yielding benefits for the patient and minimize expense on the public health system.
Study Limitations
It must be pointed out that there are only a small number of studies about the use of Oxandrolone in adults. There is a need for new randomized, double blind studies, with a larger number of patients so one could obtain quality evidence. The design should aim at demonstrating a possible shorter hospital stay, a smaller A faster and better rehabilitation of the major burn patient and the optimization of his or her quality of life would be the main goal of these studies.
